Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3214) 3214
Conference Proceeding (468) 468
Patent (171) 171
Publication (113) 113
Book Review (51) 51
Book Chapter (36) 36
Book / eBook (6) 6
Magazine Article (5) 5
Report (5) 5
Dissertation (4) 4
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1335) 1335
humans (903) 903
male (733) 733
female (555) 555
animals (517) 517
middle aged (377) 377
aged (329) 329
adult (317) 317
mice (245) 245
rats (203) 203
analysis (151) 151
hematology (138) 138
aged, 80 and over (134) 134
oncology (133) 133
physics (128) 128
expression (127) 127
research (124) 124
abridged index medicus (122) 122
astronomy & astrophysics (120) 120
surgery (117) 117
endocrinology & metabolism (116) 116
biochemistry & molecular biology (114) 114
pharmacology & pharmacy (98) 98
adolescent (89) 89
physics, applied (88) 88
urology & nephrology (88) 88
japan (85) 85
gene expression (83) 83
geochemistry & geophysics (81) 81
cell biology (78) 78
neurosciences (78) 78
immunohistochemistry (77) 77
immunology (76) 76
medicine & public health (74) 74
medicine, research & experimental (73) 73
molecular sequence data (73) 73
cancer (72) 72
time factors (72) 72
engineering, electrical & electronic (71) 71
physiological aspects (71) 71
chemistry (70) 70
retrospective studies (69) 69
rna, messenger - metabolism (68) 68
geosciences, multidisciplinary (66) 66
proteins (65) 65
cardiac & cardiovascular systems (64) 64
ophthalmology (64) 64
peripheral vascular disease (64) 64
cells (62) 62
prognosis (62) 62
cells, cultured (61) 61
disease (59) 59
magnetosphere (58) 58
physics, condensed matter (57) 57
health aspects (56) 56
mice, inbred c57bl (55) 55
disease models, animal (54) 54
gene (54) 54
ionosphere (54) 54
model (54) 54
multidisciplinary sciences (54) 54
physiology (54) 54
rats, sprague-dawley (54) 54
electricity (52) 52
pathology (52) 52
phylogeny (52) 52
amino acid sequence (51) 51
rats, wistar (51) 51
research article (51) 51
plant sciences (50) 50
microbiology (49) 49
cell line (48) 48
genetic aspects (48) 48
treatment outcome (48) 48
care and treatment (47) 47
chemistry, inorganic & nuclear (47) 47
performing operations (47) 47
transporting (47) 47
activation (46) 46
child (46) 46
protein (46) 46
system (46) 46
materials science, multidisciplinary (45) 45
biophysics (44) 44
chemistry, analytical (44) 44
identification (44) 44
mutation (44) 44
nuclear science & technology (44) 44
usage (44) 44
circadian rhythm (43) 43
crystallography (43) 43
geriatrics & gerontology (43) 43
magnetic fields (43) 43
virology (43) 43
biology (41) 41
dentistry (41) 41
evolution (41) 41
magnetospheric physics (41) 41
ring current (41) 41
rodents (41) 41
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3624) 3624
Japanese (183) 183
French (47) 47
Spanish (20) 20
German (8) 8
Chinese (4) 4
Korean (4) 4
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor Pathway
by Mitsuyo Shintani and Yoshihiro Ogawa and Ken Ebihara and Megumi Aizawa-Abe and Fumiko Miyanaga and Kazuhiko Takaya and Tatsuya Hayashi and Gen Inoue and Kiminori Hosoda and Masayasu Kojima and Kenji Kangawa and Kazuwa Nakao
Diabetes, ISSN 0012-1797, 02/2001, Volume 50, Issue 2, pp. 227 - 232
Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic... 
MESSENGER-RIBONUCLEIC-ACID | RNA | FOOD-INTAKE | Y1 RECEPTOR | ENDOCRINOLOGY & METABOLISM | RAT HYPOTHALAMUS | NEURONS | ARCUATE NUCLEUS | GH SECRETAGOGUE | OBESE | MICE LACKING | Leptin - antagonists & inhibitors | Growth Hormone - metabolism | Peptides - physiology | Injections, Intraventricular | Rats | Male | Neuropeptide Y - genetics | RNA, Messenger - metabolism | Rats, Sprague-Dawley | Growth Hormone - deficiency | Peptides - pharmacology | Peptide Hormones | Animals | Hypothalamus - metabolism | Ghrelin | RNA, Messenger - antagonists & inhibitors | Leptin - pharmacology | Hypothalamus - drug effects | Drug Combinations | Neuropeptide Y - physiology | Appetite | Physiological aspects | Somatotropin | Research | Leptin | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
by Eikelboom, John W and Connolly, Stuart J and Bosch, Jackie and Dagenais, Gilles R and Hart, Robert G and Shestakovska, Olga and Diaz, Rafael and Alings, Marco and Lonn, Eva M and Anand, Sonia S and Widimsky, Petr and Hori, Masatsugu and Avezum, Alvaro and Piegas, Leopoldo S and Branch, Kelley R.H and Probstfield, Jeffrey and Bhatt, Deepak L and Zhu, Jun and Liang, Yan and Maggioni, Aldo P and Lopez-Jaramillo, Patricio and O’Donnell, Martin and Kakkar, Ajay K and Fox, Keith A.A and Parkhomenko, Alexander N and Ertl, Georg and Störk, Stefan and Keltai, Matyas and Ryden, Lars and Pogosova, Nana and Dans, Antonio L and Lanas, Fernando and Commerford, Patrick J and Torp-Pedersen, Christian and Guzik, Tomek J and Verhamme, Peter B and Vinereanu, Dragos and Kim, Jae-Hyung and Tonkin, Andrew M and Lewis, Basil S and Felix, Camilo and Yusoff, Khalid and Steg, P. Gabriel and Metsarinne, Kaj P and Cook Bruns, Nancy and Misselwitz, Frank and Chen, Edmond and Leong, Darryl and Yusuf, Salim and COMPASS Investigators
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
In patients with stable cardiovascular disease, those receiving rivaroxaban plus aspirin had fewer major cardiovascular events but more major bleeding events... 
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | ORAL RIVAROXABAN | CLOPIDOGREL | SECONDARY PREVENTION | Atherosclerosis - drug therapy | Double-Blind Method | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Atherosclerosis - complications | Male | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Aspirin | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Research | Cardiovascular diseases | Drug therapy | Observations | Methods | Myocardial infarction | Cerebral infarction | Medical research | Cardiovascular disease | Bleeding | Studies | Disease prevention | Arteriosclerosis | Coronary vessels | Atherosclerosis | Drug dosages | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Rapid publication ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway
by Shintani, Mitsuyo and Ogawa, Yoshihiro and Ebihara, Ken and Aizawa-Abe, Megumi and Miyanaga, Fumiko and Takaya, Kazuhiko and Hayashi, Tatsuya and Inoue, Gen and Hosoda, Kiminori and Kojima, Masayasu and Kangawa, Kenji and Nakao, Kazuwa
Diabetes, ISSN 0012-1797, 2001, Volume 50, Issue 2, pp. 227 - 232
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis
by Bhatt, Deepak L and Steg, P. Gabriel and Ohman, E. Magnus and Hirsch, Alan T and Ikeda, Yasuo and Mas, Jean-Louis and Goto, Shinya and Liau, Chiau-Suong and Richard, Alain J and Röther, Joachim and Wilson, Peter W. F and REACH Registry Investigators, for the and REACH Registry Investigators
JAMA, ISSN 0098-7484, 01/2006, Volume 295, Issue 2, pp. 180 - 189
CONTEXT Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single international database has... 
GLOBAL BURDEN | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | QUALITY | WAIST CIRCUMFERENCE | MYOCARDIAL-INFARCTION | OVERWEIGHT | ATHEROSCLEROSIS | BODY-MASS INDEX | ACUTE CORONARY SYNDROMES | BMI | Prevalence | Global Health | Humans | Middle Aged | Risk Factors | Cardiovascular Diseases - therapy | Male | Thrombosis - epidemiology | Atherosclerosis - epidemiology | Drug Utilization | Outpatients | Atherosclerosis - therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Registries | Aged | Platelet Aggregation Inhibitors - therapeutic use | Thrombosis - therapy | Care and treatment | Atheroembolism | Cardiovascular diseases | Risk factors | Blood vessels | Cardiovascular disease | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights